4D Molecular Therapeutics Insider Sold Shares Worth $811,004, According to a Recent SEC Filing
MT newswire2026/09/16 21:25Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
05:25 PM EDT, 09/16/2026 (MT Newswires) -- David Kirn, Director, President and Chief Executive Officer, on September 14, 2026, sold 58,333 shares in 4D Molecular Therapeutics (FDMT) for $811,004. Following the Form 4 filing with the SEC, Kirn has control over a total of 767,486 common shares of the company, with 767,486 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650648/000119312526393243/xslF345X05/ownership.xml
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
J.Jill Files for Sale of Common Shares
MT newswire•2026/09/16 21:49
New Zealand GDP in the barrel with the Kiwi at July lows
FXStreet•2026/09/16 21:48
Oil Heiress's $1.9 Billion Stock Sale Sinks Diamondback Shares -- WSJ
Dow Jones•2026/09/16 21:39
Market Chatter: Exxon Mobil Close to Preliminary Venezuela Oil Investment Deal
MT newswire•2026/09/16 21:39
